UC Berkeley |

FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease

UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version.

UCSF |

What’s so controversial about the first gene-edited babies? Experts explain

Researcher He Jiankui’s announcement of the first babies with DNA edited as embryos causes concern.

UC Berkeley and UCSF |

The first genome surgeons

CRISPR opens door to new type of medicine: “genome surgery.”

UC Berkeley |

CRISPR reduces autism symptoms in mice

Exaggerated repetitive behavior characteristic of autism was lessened after a receptor was edited.

UC Berkeley |

First step toward CRISPR cure of Lou Gehrig’s disease

Scientists disable a muscle degeneration trigger to extend mouse lifespans by 25 percent.

UC Berkeley |

Pac-Man-like CRISPR enzymes have potential for disease diagnostics

Jennifer Doudna's lab discovers an application that could identify viruses like Zika cheaply and quickly.